Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis [Yahoo! Finance]
Lindsay Corporation (LNN)
Last lindsay corporation earnings: 4/7 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
lindsayir.com
Company Research
Source: Yahoo! Finance
Once approved, the test will aid healthcare providers in identifying amyloid pathology, a key feature of Alzheimer's disease Roche and Lilly believe the test could play an important role in improving access to early and accurate Alzheimer's diagnosis Basel, 11 April 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its Elecsys pTau217 assay received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). This blood test, which is being developed in collaboration with Eli Lilly and Company, will be used to help identify the presence or absence of amyloid pathology in individuals, which can help ensure they are able to receive appropriate care. This may include participation in clinical trials or access to approved disease-modifying therapies. If approved, the test could help rapidly broaden access to a more timely and accurate diagnosis and potentially mitigate the impact of Alzheimer's disease on people and society. “The incidence of demen
Show less
Read more
Impact Snapshot
Event Time:
LNN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LNN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LNN alerts
High impacting Lindsay Corporation news events
Weekly update
A roundup of the hottest topics
LNN
News
- Lindsay Co. (NYSE: LNN) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Why Roche Holdings Stock Popped Today [Yahoo! Finance]Yahoo! Finance
- Roche, Eli Lilly gain FDA breakthrough device tag for Alzheimer's blood test [Seeking Alpha]Seeking Alpha
- Roche, Eli Lilly Alzheimer's Blood Test to Get Expedited FDA Review [MarketWatch]MarketWatch
- Micro Irrigation and Mechanized Systems Market To Reach USD 50.5 Billion By 2032 - DataHorizzon Research [Yahoo! Finance]Yahoo! Finance
LNN
Earnings
- 4/4/24 - Beat
LNN
Sec Filings
- 4/4/24 - Form 10-Q
- 4/4/24 - Form 8-K
- 2/13/24 - Form SC
- LNN's page on the SEC website